Corcept Oncology President Roberto Wandenkolk Vieira disposes of USD 6.31 million in common shares
CORT•Vieira cuts direct stake after Sept. 2 transactions
Roberto Wandenkolk Vieira, President, Oncology, cut his direct stake in Corcept to 4,242 shares following Sept. 2 transactions.
- Disposed of 58,333 shares at USD 21.63 in an option exercise, then sold 58,333 shares in multiple trades at about USD 109.35 to USD 115.44.
- Also acquired 276 shares on Sept. 1, including 138 shares bought at USD 113.38.
